Dr. Reddy's Laboratories Limited Missed Consensus Estimates

Dr. Reddy's Laboratories Limited (RDY) reported earnings of $0.06 per share on revenue of $853.00 million for the fiscal first quarter ended June 2026. The consensus earnings estimate was $0.17 per share on revenue of $925.53 million. The company missed consensus estimates by 64.71% while revenue fell 14.44% compared to the same quarter a year ago.

Dr Reddy Laboratories Ltd together with its subsidiaries is engaged in manufacturing of pharmaceutical products. It operates through three segments; Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products.